Call: +44 (0)8707 705168 Email: Shopping basket: 0 item(s) view basket
Call us on: +44 (0)8707 705168

SphygmoCor CPVH

SphygmoCor CPVH

If you would like more info about this product
Please call +44 (0)8707 705168
Or go to our Contact Us page by clicking here

Product Information

The SphygmoCor CPH has the same functionality as the SphygmoCor CP system but also the added advantage of Heart Rate Variability measurement.
The SphygmoCor CPH system acquires the patient’s radial pulse waveform non-invasively by applanation tonometry.
Critical cardiovascular measurements include:
  • Aortic Augmentation Index and Pressure
  • Ejection Duration
  • Subendocardial Viability Ratio.
The system may facilitate early identification of cardiovascular risk, and is essential for the management of patients with hypertension, diabetes, diastolic heart failure, and other high cardiovascular risk conditions such as renal disease and hypercholesterolaemia.

SphygmoCor CPH Applications:

  • Evaluation of arterial stiffness and its clinical impact
  • Improved patient evaluation in hypertension, diabetes and cardiac failure
  • Early identification of "at risk" diabetes patients
  • Monitoring at the heart of the effect of drug intervention 


  • Coronary artery perfusion pressure throughout the cardiac cycle.
  • Instantaneous calculation of key parameters,including:
    • Heart Rate Variability
    • Aortic Pulse Pressure
    • Aortic Systolic Pressure
    • Aortic Systolic Pressure
    • Aortic Augmentation Index
    • Left ventricular load- Pulse pressure in the left ventricle and in the ascending aorta (driving cerebral blood flow)
    • Central systolic pressure (as seen by the baro-receptors), which can be markedly different from the cuff value
    • Ejection duration in relation to cardiac cycle
  • Evaluation of arterial stiffness and its clinical impact on the heart
  • A powerful index of subendocardial viability
  • Automatic, real-time QA feedback leading to minimal operator variability
  • Noninvasive test


  • Central pressure has been shown to be a superior,independent predictor of future cardiovascular events than peripheral pressure
  • Allows assessment of drug effects that cannot be detected with brachial pressure measurements
  • Provides patients with visual evidence of the effects of lifestyle changes and drug therapies
  • Comfortable for patients
  • No disposables required.

Related Products

Smart Medical - Cotswold Business Village - Moreton in Marsh - Gloucestershire - GL56 0JU - United Kingdom
Tel: +44 (0)8707 705168 - Fax: +44 (0)8707 705169 - E-mail:

SMART Medical is UK registered, Registration No. 4495074 Registered at Kenton House, Oxford Street, Moreton in Marsh, Gloucestershire, GL56 0LA
VAT Registration No. : 794 0516 16

Skip navigation links